Yes, that data is for the Delta variant, which is pretty much irrelevant for Omicron. There is no evidence that the vaccines will provide significant protection against infection. There is speculation is that the vaccines might reduce severity of symptoms, but they are usually very mild to begin with.

Johnson & Johnson’s vaccine produced virtually no antibody protection against the omicron coronavirus variant in a laboratory experiment, underlining the new strain’s ability to get around one pillar of the body’s defenses.

Lying down with a paper bag over your head is likely to give a similar level of protection.

My take is, smart money is on lose weight, get in shape, and get ready for covid because pretty much all of us are getting it at some point. The vaccine will end the pandemic fairy has left the building.

3 Likes

Do you get a flu shot every year?

No, and I haven’t had the flu since high school.

First of all, not true:

Second, obviously Omicron isn’t the only variant out there.

from your link.

“Immediately post booster there may be a stronger protective effect,” Hamer said.

Sorry, a two or three-month boost isn’t worth more Covid spikes in my organs. I’ll take my current 70% reduction in hospitalization and call it a day.

Lucky you.

Probably start to take it when I get decrepit.

I get a yearly flu shot.

No big deal.

So you’ll get a yearly vaccine for a virus that has different variants?

This is looking more like quarterly. And what damaging material is in a flu shot? Covid spikes damage organs and blood vessels.

Yes because it doesn’t cause my body to make damaging protein spikes.

1 Like

Well… that is just making stuff up.

You don’t think covid protein spikes damage organs and blood vessels?

Did you hear that from a medical professional ? i.e. did your doctor say that ?

How… how could they? The antibody response to them has a small chance of doing some adverse damaage, but the risk is far far lower than actually getting sick from an infection.

Will peer reviewed work?

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538446/

In contrast, our data provide valuable details on the involvement of spike protein subunits in DNA damage repair, indicating that full–length spike–based vaccines may inhibit the recombination of V(D)J in B cells, which is also consistent with a recent study that a full–length spike–based vaccine induced lower antibody titers compared to the RBD–based vaccine [28]. This suggests that the use of antigenic epitopes of the spike as a SARS–CoV–2 vaccine might be safer and more efficacious than the full–length spike. Taken together, we identified one of the potentially important mechanisms of SARS–CoV–2 suppression of the host adaptive immune machinery. Furthermore, our findings also imply a potential side effect of the full–length spike–based vaccine. This work will improve the understanding of COVID–19 pathogenesis and provide new strategies for designing more efficient and safer vaccines.

That is an in vitro study… not in vivo… and… you get far more exposure to the spike protein with an actual infection than with vaccination.

The risk of vaccination is far lower.

But not risk free.

1 Like

Nothing is.

But less risk from the vaccination than with an infection… with an infection you get… well… sick and can possibly die.